Breaking News Instant updates and real-time market news.

AGN

Allergan

$229.72

1.78 (0.78%)

16:01
10/19/16
10/19
16:01
10/19/16
16:01

FDA panel votes in support of Allergan Nocturia approval, Bloomberg reports

The advisory panel voted 14-4 that the benefits of the nasal spray outweigh the risks, supporting a potential approval, according to Bloomberg.

  • 26

    Oct

  • 02

    Nov

  • 06

    Nov

AGN Allergan
$229.72

1.78 (0.78%)

09/21/16
GABE
09/21/16
NO CHANGE
GABE
Buy
Gabelli questions if Allergan could target Gilead next
Gabelli analyst Kevin Kedra said that "like most" he was surprised at the price paid and the strategic fit of Allergan's (AGN) deal to buy Tobira Therapeutics (TBRA), but wonders if Allergan CEO Brent Saunders is "playing chess while the market is playing checkers" and could be preparing a bid for Gilead (GILD). After Allergan's "very loud statement about its commitment to NASH and liver disease," a deal for Gilead, the leading company in liver disease and "one of the cheapest companies in pharma/biotech," would appear to make more sense, Kedra tells investors, adding that an acquisition of Gilead at a price of $115 per share would be "highly accretive" for Allergan. The analyst keeps a Buy rating on Allergan shares.
09/22/16
BERN
09/22/16
NO CHANGE
BERN
Allergan acquisitions positive, says Bernstein
After Allergan bought two companies with NASH drugs and the stock fell, Bernstein analyst Aaron Gal says the acquisitions were viewed as expensive. Gal says "it makes almost no difference" if the deals were expensive, as the important issue is whether the products succeed. He believes that the market would never penalize Roche or Celgene for similar deals, and he thinks this indicates that Allergan is "misvalued." He says that Allergan is his "high conviction buy" stock and keeps a $335 price target on the shares.
09/26/16
LEER
09/26/16
NO CHANGE
LEER
Shire Xiidra launch to 'significantly' expand dry eye category, says Leerink
Leerink analyst Jason Gerberry remains optimistic that Shire's (SHPG) Xiidra launch will "significantly" expand the category for dry eye disease brands, while not meaningfully eroding Allergan's (AGN) Restasis market leading position. While it's still early in the launch of Xiidra and payer access remains a critical variable, the analyst does not anticipate access being a major barrier. Gerberry reiterates an Outperform rating on both Shire and Allergan's shares.
10/14/16
LEER
10/14/16
NO CHANGE
Target $294
LEER
Outperform
Leerink positive on Allergan ahead of Restasis patent decision
Leerink analyst Jason Gerberry is positive on Allergan's franchise outlook as he believes the company will either maintain a double-digit top-line" growth pharma" trajectory or alternatively institute a dividend, and will prevail in the ongoing Restasis patent challenge. Gerberry likes Allergan's underlying growth trends of the gastro and derm franchises and pipeline optionality, and reiterates an Outperform rating and $294 price target on the shares.

TODAY'S FREE FLY STORIES

KEX

Kirby

$64.35

0.35 (0.55%)

16:20
09/25/17
09/25
16:20
09/25/17
16:20
Hot Stocks
Breaking Hot Stocks news story on Kirby »

Hushang Ansary reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

SNWV

Sanuwave Health

$0.14

0.015 (12.50%)

16:20
09/25/17
09/25
16:20
09/25/17
16:20
Conference/Events
Sanuwave Health to host business news update conference call »

Management provides a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PKY

Parkway

$23.00

-0.02 (-0.09%)

16:20
09/25/17
09/25
16:20
09/25/17
16:20
Hot Stocks
Parkway announces special cash dividend of $4.00 per share »

Parkway announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CQP

Cheniere Energy Partners

$27.40

0.37 (1.37%)

16:19
09/25/17
09/25
16:19
09/25/17
16:19
Initiation
Cheniere Energy Partners initiated  »

Cheniere Energy Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHT

Red Hat

$105.76

-0.54 (-0.51%)

16:19
09/25/17
09/25
16:19
09/25/17
16:19
Hot Stocks
Red Hat reports Q1 subscription revenue up 14% in constant currency »

Subscription revenue from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

PKY

Parkway

$23.00

-0.02 (-0.09%)

16:18
09/25/17
09/25
16:18
09/25/17
16:18
Hot Stocks
Parkway says shareholders approve merger with affiliate of CPPIB »

Parkway announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

LNG

Cheniere Energy

$44.08

0.6 (1.38%)

16:18
09/25/17
09/25
16:18
09/25/17
16:18
Initiation
Cheniere Energy initiated  »

Cheniere Energy initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RHT

Red Hat

$105.76

-0.54 (-0.51%)

16:18
09/25/17
09/25
16:18
09/25/17
16:18
Earnings
Red Hat raises FY18 adjusted EPS view to $2.77-$2.79 from $2.66-$2.70 »

Consensus $2.69. Raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

RHT

Red Hat

$105.76

-0.54 (-0.51%)

16:18
09/25/17
09/25
16:18
09/25/17
16:18
Earnings
Red Hat sees Q3 adjusted EPS roughly 70c, consensus 70c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

CRAY

Cray

$18.13

-0.475 (-2.55%)

, STX

Seagate

$33.16

-0.41 (-1.22%)

16:17
09/25/17
09/25
16:17
09/25/17
16:17
Hot Stocks
Cray finishes strategic transaction of Seagate's ClusterStor business »

Cray (CRAY) announced it…

CRAY

Cray

$18.13

-0.475 (-2.55%)

STX

Seagate

$33.16

-0.41 (-1.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNX

Synnex

$116.50

0.4 (0.34%)

16:17
09/25/17
09/25
16:17
09/25/17
16:17
Hot Stocks
SYNNEX raises quarterly dividend 20% to 30c per share »

The dividend will be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

$NSD

NASDAQ Market Internals

16:17
09/25/17
09/25
16:17
09/25/17
16:17
Technical Analysis
NASDAQ market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNX

Synnex

$116.50

0.4 (0.34%)

16:17
09/25/17
09/25
16:17
09/25/17
16:17
Earnings
SYNNEX sees Q4 adjusted EPS $2.63-$2.73, consensus $2.49 »

Sees Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

RHT

Red Hat

$105.73

-0.57 (-0.54%)

16:16
09/25/17
09/25
16:16
09/25/17
16:16
Earnings
Red Hat reports Q2 adjusted EPS 77c, consensus 67c »

Reports Q2 revenue $723M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SNX

Synnex

$116.59

0.485 (0.42%)

16:16
09/25/17
09/25
16:16
09/25/17
16:16
Hot Stocks
Breaking Hot Stocks news story on Synnex »

SYNNEX raises quarterly…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

$NYE

NYSE Market Internals

16:16
09/25/17
09/25
16:16
09/25/17
16:16
Technical Analysis
NYSE market internals summary »

Volume was average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IVTY

Invuity

$7.80

-0.5 (-6.02%)

16:15
09/25/17
09/25
16:15
09/25/17
16:15
Hot Stocks
Invuity announces commercial launch of PhotonBlade »

Invuit announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Nov

SNX

Synnex

$116.59

0.485 (0.42%)

16:15
09/25/17
09/25
16:15
09/25/17
16:15
Earnings
Synnex reports Q3 adjusted EPS $2.16, consensus $1.97 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 16

    Oct

  • 17

    Oct

KDMN

Kadmon

$3.83

0.31 (8.81%)

16:13
09/25/17
09/25
16:13
09/25/17
16:13
Syndicate
Kadmon files to sell common stock and warrants »

Kadmon announced its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

PRQR

ProQR Therapeutics

$6.45

0.25 (4.03%)

16:12
09/25/17
09/25
16:12
09/25/17
16:12
Conference/Events
ProQR Therapeutics to hold a conference call »

Management discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

LAUR

Laureate Education

$14.10

-0.31 (-2.15%)

16:11
09/25/17
09/25
16:11
09/25/17
16:11
Hot Stocks
Breaking Hot Stocks news story on Laureate Education »

12 West Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

SSKN

STRATA Skin Sciences

$1.81

0.12 (7.10%)

16:11
09/25/17
09/25
16:11
09/25/17
16:11
Hot Stocks
STRATA Skin Sciences closes pact to eliminate $40.7M in convertible debentures »

STRATA Skin Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ENV

Envestnet

$49.85

-0.45 (-0.89%)

, ACTA

Actua

$12.25

-0.1 (-0.81%)

16:11
09/25/17
09/25
16:11
09/25/17
16:11
Hot Stocks
Envestnet to acquire FolioDynamix »

Envestnet (ENV) announced…

ENV

Envestnet

$49.85

-0.45 (-0.89%)

ACTA

Actua

$12.25

-0.1 (-0.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

CTLT

Catalent

$40.74

-0.02 (-0.05%)

16:10
09/25/17
09/25
16:10
09/25/17
16:10
Syndicate
Catalent files to sell $250M in common stock »

Morgan Stanley, JPMorgan,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACTA

Actua

$12.25

-0.1 (-0.81%)

16:08
09/25/17
09/25
16:08
09/25/17
16:08
Hot Stocks
Actua in pacts to sell three majority-owned businesses for $549M »

Actua Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.